These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35361860)

  • 1. Transcriptome-wide analysis of glioma stem cell specific m6A modifications in long-non-coding RNAs.
    Steponaitis G; Stakaitis R; Valiulyte I; Krusnauskas R; Dragunaite R; Urbanavičiūtė R; Tamasauskas A; Skiriute D
    Sci Rep; 2022 Mar; 12(1):5431. PubMed ID: 35361860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
    Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
    Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With
    Yang J; Yang Q; Zhang J; Gao X; Luo R; Xie K; Wang W; Li J; Huang X; Yan Z; Wang P; Gun S
    Front Immunol; 2021; 12():769204. PubMed ID: 34880865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
    Wu J; Deng LJ; Xia YR; Leng RX; Fan YG; Pan HF; Ye DQ
    Mol Immunol; 2022 Mar; 143():77-84. PubMed ID: 35051888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer.
    Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J
    J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
    Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
    Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome-wide N6-methyladenosine modification profiling of long non-coding RNAs during replication of Marek's disease virus in vitro.
    Sun A; Zhu X; Liu Y; Wang R; Yang S; Teng M; Zheng L; Luo J; Zhang G; Zhuang G
    BMC Genomics; 2021 Apr; 22(1):296. PubMed ID: 33888086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
    Zhang S; Shao Y; Li D; Li C
    Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scoring model based on the signature of non-m6A-related neoantigen-coding lncRNAs assists in immune microenvironment analysis and TCR-neoantigen pair selection in gliomas.
    Zhao W; Wu Y; Zhao F; Xue Z; Liu W; Cao Z; Zhao Z; Huang B; Han M; Li X
    J Transl Med; 2022 Oct; 20(1):494. PubMed ID: 36309750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of lncRNAs N
    Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
    Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal m6A modification in non-alcoholic fatty liver disease.
    Li Z; Qi J; Liu H; Tang Y; Liu J; Sun C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):785-792. PubMed ID: 34565720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alteration of N6-methyladenosine (m6A) modification at the transcriptome-wide level in response of heat stress in bovine mammary epithelial cells.
    Qi Y; Zhang Y; Zhang J; Wang J; Li Q
    BMC Genomics; 2022 Dec; 23(1):829. PubMed ID: 36517742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Roles of Long Non-Coding RNAs (LncRNAs) in Glioma Stem Cells.
    Wang L; He Z
    Med Sci Monit; 2019 Oct; 25():7567-7573. PubMed ID: 31593561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
    Wu J; Cai Y; Zhao G; Li M
    J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental exposures and RNA N6-Methyladenosine modified long Non-Coding RNAs.
    Cayir A
    Crit Rev Toxicol; 2020 Sep; 50(8):641-649. PubMed ID: 32924714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.